Mid-point pricing, oversubscribed issuance: Bambusa (BBTX.US) IPO raises $169 millions, locking in a valuation of $815 millions

智通财经2026/10/30 02:50

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

财经APP Zhihu reports that Bambusa Therapeutics Inc. (BBTX.US), an early-stage biotech company focused on dermatological and autoimmune diseases, raised USD 168.9 million through an upsized US initial public offering (IPO), pricing at the midpoint of its indicated range.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Mid-point pricing, oversubscribed issuance: Bambusa (BBTX.US) IPO raises $169 millions, locking in a valuation of $815 millions

You may also like

Crypto prices